$4M in Seed Funding to Start a Prenatal Health Revolution
We are happy to announce that Bloomlife has officially closed a $4 million seed funding round led by investors like Marc Benioff and Efficient Capacity, LanzaTech Ventures, The Chernin Group, Kapor Capital, and Act One Ventures. This round brings Bloomlife’s total funding to $6M.
Over the past two years, we have developed a state-of-the-art, clinically validated sensor that can measure the most important health parameters of mom and baby from conception to birth. This technology fuels our mission to revolutionize prenatal care by using crowdsourced data to better understand pregnancy and pregnancy complications. The potential for this technology has already garnered top honors as winner of the Extreme Tech Challenge on Sir Richard Branson’s Necker Island earlier this year.
“Our company’s mission resonated with the judges of the Extreme Tech Challenge,” said Eric Dy, CEO and co-founder. “They understood what it means to have a pregnancy go well and how our technology could help this under served market.”
Since our inception, we have worked hard to form strategic partnerships that further our field of expertise, building credibility as leaders in the industry. We have an ongoing partnership with Stanford and the University of California, San Francisco (UCSF)’s Preterm Birth Initiative.
With the new funding, we will focus on building out commercialization efforts for the first product, the only smart pregnancy wearable that automatically detects and tracks contractions allowing expectant moms to visualize the information on their smartphone. With this innovative technology, the expectant mom can better understand her body and gain peace of mind throughout the third trimester.
“Every pregnancy is unique and expectant moms are looking for validation of what they are feeling. Boomlife provides an objective second opinion.”, says Eric Dy, CEO and co-founder.
The Bloomlife smart pregnancy wearable is only available through an exclusive Early Access Program on our website www.bloomlife.com until launch.
Funding will also be used to accelerate commercialization of next features on the unique wearable platform.
Founded in 2014 by Eric Dy, PhD and Julien Penders, MSc and based in San Francisco with offices in Belgium, Bloomlife is a digital health company designing the future of prenatal care with technology to improve the health of moms and babies. Bloomlife is developing smart pregnancy wearables that measure important health parameters of mom and baby from conception to birth. By combining wearable technology with data analytics, Bloomlife strives to provide moms and clinicians with better information to improve birth outcomes.